Skip to content

Oral Human Papillomavirus Infection in HIV-infected Men

Incidence, Prevalence, Spectrum of HPV-types, and Viral Load Determination of High-risk Human Papillomavirus Infection of the Oral Cavity in HIV-infected Men Who Have Sex With Men

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00421486
Enrollment
500
Registered
2007-01-12
Start date
2006-03-31
Completion date
2018-01-31
Last updated
2016-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Papillomavirus Infections

Keywords

Oral human papillomavirus infection, HIV-infection, High-risk HPV viral load, Oral human papillomavirus infection in HIV-positive men, Treatment Experienced, Treatment Naive

Brief summary

Human papillomavirus (HPV)-infection belong to the most common sexually transmitted diseases worldwide. HIV-infected men having sex with men /MSM) are strongly associated with a higher prevalence of genitoanal HPV-infection, and perianal HPV-infections have been detected in up to 90% of HIV-positive men. The data concerning the incidence of oral HPV-infection in HIV-positive men, especially in the era of highly antiretroviral therapy, are conflicting. Thus, this prospective study mainly focuses on the incidence and prevalence of oral HPV-infection, spectrum of HPV-types, and oral high-risk HPV viral load in HIV-positive men.

Detailed description

Human papillomavirus (HPV)-infection belong to the most common sexually transmitted diseases worldwide. Estimated prevalences of subclinical genital HPV-infection in the immunocompetent sexually active population range from 10 to above 50%. Genetic or iatrogenic immunosuppression is known to play a decisive role in the initiation of a variety of cutaneous neoplasias and their precursor lesions. In this context, HPV-associated anogenital malignancies occur with high frequency in patients with HIV-infection. In several studies, perianal HPV-infections have been detected in up to 90% of HIV-positive men and a high incidence of anal dysplasia has been reported in these patients. The data concerning the incidence of oral HPV-infection in HIV-positive men, especially in the era of highly antiretroviral therapy, are conflicting. Thus, this prospective study mainly focuses on the incidence and prevalence of oral HPV-infection, spectrum of HPV-types, and oral high-risk HPV viral load in HIV-positive men.

Interventions

PROCEDUREOral swabs for HPV-typing and high-risk HPV-determination

Oral swabs for HPV-typing and high-risk HPV-determination

Sponsors

Deutsche Luft und Raumfahrt
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* HIV-infected men who have sex with men

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Spectrum of HPV types and associated clinical lesionsswabs will be obtained approximately every 6 months

Countries

Germany

Contacts

Primary ContactAlexander Kreuter, MD
a.kreuter@derma.de0049/234/5093439

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026